Immunotherapy with Pembrolizumab beyond Progression and Local Ablative Therapy in Oligoprogressive metastatic NSCLC.
A. Oseledchyk
Leopold Haecker
A. Schmitt
T. Wallrabenstein
T. Finazzi
David König
Sacha I. Rothschild
Medicine